This announcement contains inside information for the purposes of Article 7 of the
("
Equity Subscription and Restoration of Trading
Further to the Company's announcement on
Consequently, as the Company has met the requirement to raise a minimum of
As previously announced, the Company is seeking to raise further material new investment of a minimum of
Discussions with interested parties that are significant holders of late-stage private tech companies are ongoing for in-kind contributions.
Whilst there can be no certainty regarding its completion, this First Phase Fundraising targets to issue shares at the same price as the Preliminary Fundraising of
The Company will provide a further update regarding the First Phase Fundraising when and if necessary.
Admission and Total Voting Rights
Application will be made to AIM for 8,350,000 new ordinary shares ("Preliminary Fundraising Shares") to be admitted to trading on AIM as well as the 25,000 shares subject to the conversion notice as announced on
In accordance with the provision of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the Preliminary Fundraising Shares, its issued ordinary share capital will comprise 10,760,193 ordinary shares. All the ordinary shares have equal voting rights. The above figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interests in, or change to their interest in, the Company.
For further information, please contact:
+44 (0) 778 531 5588
Zeus - Nominated Adviser & Broker
+44 (0) 203 829 5000
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the